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Abstract
Background: To evaluate basal testosterone (T) levels during follicular phase of the menstrual cycle as a predictor
for ovarian response and in vitro fertilization (IVF) outcome.
Method: We analyzed data retrospectively from hospital-based IVF center including one thousand two hundred
and sixty Chinese Han women under their first IVF cycle reached the ovum pick-up stage, without polycystic ovary
syndrome (PCOS) or endometriosis undergoing long IVF protocol. Patients were divided into 2 groups. Group 1:
patients with diminished ovarian reserve (basal FSH >10 IU/L) (n = 187); Group 2: patients with normal ovarian
reserve (basal FSH < = 10 IU/L) (n = 1073). We studied the association of basal T levels with ovarian response and
IVF outcome in the two groups. Long luteal down-regulation protocol was used in all patients, that is, the
gonadotropin releasing hormone agonist was administered in the midluteal phase of the previous cycle and use of
recombinant FSH was started when satisfactory pituitary desensitization was achieved.
Results: Basal T levels were markly different between pregnant and non-pregnant women in Group 1; whereas not
in Group 2. A testosterone level of 47.85 ng/dl was shown to predict pregnancy outcome with a sensitivity of
52.8% and specificity of 65.3%; and the basal T was correlated with the numbers of large follicles (> 14 mm) on
HCG day in Group 1. Significantly negative correlations were observed between basal T, days of stimulation and
total dose of gonadotropins after adjusting for confounding factors in both groups.
Conclusion: In women with diminished ovarian reserve, basal T level was a predictor for the number of large
follicles on HCG day and pregnancy outcome; but could not in those with normal serum FSH. Basal T levels were
associated with both days of stimulation and total dose of gonadotropins, indicating that lower level of T might
relate with potential ovarian poor response.
Background
Ovarian response, the recruitment and development of
multiple follicles followed by gonadotropins, is a key fac-
tor for in vitro fertilization (IVF) treatment cycle. The
prediction of ovarian response before undertaking the
expensive IVF treatment is important. However, the pre-
dictive value of various widely used markers, such as
age, antral follicle count (AFC), levels of serum inhibin
B, serum anti-Müllerian hormone (AMH), basal serum
follicle stimulating hormone (FSH) and estradiol (E2),
basal FSH/LH (luteinizing hormone) ratio, still appeared
inconsistent and not accurate enough. A large amount
of patients may respond poorly to gonadotropins in
spite of normal screening parameters [1]. Therefore, it
continues to be a challenge for reproductive physicians
to identify poor ovarian reserve and the probability of
pregnancy beforehand.
Androgens, primarily testosterone (T) and androstene-
dione, are noteworthy to enhance follicular recruitment
[2], promote follicular growth and development [3,4],
and increase insulin like growth factor 1 (IGF-1) expres-
sion in the primate ovary which plays an essential role
in regulating follicular development [3,5]. Recent clinical
reports with encouraging results demonstrated that co-
treatment with androgen, such as dehydroepiandroster-
one (DHEA) and Androderm (transdermal testosterone),
could increase both quantity and quality of oocytes and
embryos, and improve pregnancy outcomes in women
with diminished ovarian function or even premature
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any medium, provided the original work is properly cited.ovarian failure [6-9]. Improved controlled ovarian hyper-
stimulation (COH) and pregnancy outcomes by supple-
mentation with aromatase inhibitors may be the
consequence of increased intraovarian androgen, fol-
lowed by the induction of FSH receptors on granulosa
cell [10,11]. Nevertheless, controversy exists as to
whether these protocols improve cycle outcome [12,13].
Prompted by these findings, we hypothesized whether
serum testosterone levels could predict ovarian response
and IVF outcome. To the best of our knowledge, only a
few studies have concerned this question with conflict-
ing results. This might be explained by limited sample
size and heterogeneous population mixed by patients
with polycystic ovary syndrome (PCOS) and/or endome-
triosis as PCOS and endometriosis are associated with
higher or lower serum T levels [14,15]. No published
study focus on the role of basal T levels during stimula-
tion cycle on the ovarian response and reproductive out-
comes in women with either diminished or normal
ovarian reserve. Thus, conclusive and definite data
about the associations of basal serum T levels with ovar-
ian response and IVF outcome are still lacking. The pur-
pose of the present study is to evaluate the predictive
value of basal T levels in women with both diminished
and normal ovarian reserve on ovarian response and
IVF outcome in a large (n = 1260) and homogeneous
population undergoing IVF-ET.
Methods
Study population
One thousand two hundred and sixty Chinese Han
patients under their first IVF-ET cycle reached the
ovum pick-up stage undergoing IVF in the Center for
Reproductive Medicine, Shandong Provincial Hospital,
Shandong University from October, 2008 to January,
2010 were recruited. And we selected women who used
only long protocol to avoid possible bias from different
protocols. Exclusion criteria were women with either
PCOS or endometriosis. Patients were divided into 2
groups. Group 1 included patients with diminished
ovarian reserve (n = 187) and Group 2 with normal
ovarian reserve (n = 1073). Diminished ovarian reserve
was defined as basal FSH value >10 IU/L [13]. We stu-
died the association of basal T levels with ovarian
response and IVF outcome in the two groups. Informed
consent was obtained from all subjects. This study
received institutional review board approval from the
ethical committee of Shandong University.
Study protocol
Long luteal down-regulation protocol was used in all
patients. Briefly, the gonadotropinreleasing hormone
(GnRH) agonist (0.1 mg/ampoule, Tryptorelin, Ferring,
Germany) was administered in the midluteal phase of
the previous cycle until the day of HCG administration.
After onset of menstrual bleeding, when satisfactory
pituitary desensitization was achieved (serum E2 level
was lower than 50 pg/ml), gonadotropin stimulation was
started with a daily use of recombinant FSH (75 U/
ampoule, Gonal F, Serono. Ltd, Switzerland). The dose
of gonadotropins was adjusted according to follicular
growth monitored by transvaginal ultrasonography and
serum E2 concentrations. HCG (10,000 IU) (Lizhu. Ltd,
Guangdong, China) was given when at least two follicles
reached 18 mm in diameter and 36 hours later oocytes
were retrieved by transvaginal ultrasound-guided follicu-
lar aspiration. Up to three embryos per patient were
transferred (2 embryos were transferred for women aged
<35 years old and in their first treatment cycle, 3
embryos were transferred for women aged ≥ 35 years
old or ≥ 2 treatment cycles) 2 or 3 days after oocytes
retrieval and the luteal phase was supported with pro-
gesterone (20 mg/ampoule, Xianju Ltd, Zhejiang,
China). A positive pregnancy was defined by > 5 IU/L of
plasma b-hCG on 14 days after embryo transfer. The
fertilization rate was defined as the number of oocytes
with two pronuclei after insemination divided by the
number of oocytes inseminated. The spontaneous mis-
carriage was defined as both biochemical and clinical
miscarriages. The good quality embryos were defined as
embryos developed from normal fertilized eggs with no
fragmentation or no more than 1/3, no presence of mul-
tinucleation, 3~5 blastomeres at 48 hours after egg
retrieval and at least 7 blastomeres by 72 h [16].
Hormone assays
On day 2 to 4 of the menstrual cycle, basal serum levels of
T, FSH, E2 and LH were obtained from each subject. All
the serum levels were determined by the electrochemilumi-
nescent immunoassay in the analyzer cobas e 601 (Roche,
Switzerland). The analytical sensitivity of basal T, FSH, LH,
E2 and b-hCG levels was 0.42 ng/ml, < 0.10 mIU/ml, 0.10
mIU/ml, 5.0 pg/ml and < 0.1 mIU/ml, respectively.
Statistical analysis
The pretreatment parameters included age, body mass
index (BMI), pregnancy history, AFC, starting doses of
gonadotropins and basal levels of FSH, E2, LH, and T.
To assess the predictive value of basal T levels to the
ovarian response, we studied the associations of basal T
levels with the number of oocytes retrieved, number of
follicles >14 mm on HCG day, basal FSH/LH ratio, days
of stimulation and total dose of gonadotropins.
To evaluate IVF outcome, we analyzed the following
variables: endometrial thickness on HCG day, fertiliza-
tion rate, number of embryos cryopreserved, number of
good quality embryos, pregnancy and spontaneous mis-
carriage outcome and live births.
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were performed to examine the differences in means
between the pregnant group and the non-pregnant
group. Pearson correlation tests and partial correlation
analyses were used to assess the relationship between
basal T levels and the continuous parameters. Multiple
linear regression analyses were used to find the possible
independent determinants of test variables among those
parameters showing significant correlations and their
contributions. The area under the receiver operating
characteristic curve (ROC) was performed to examine
the predictive value for pregnancy and spontaneous
miscarriage outcome. Data were analyzed with SPSS sta-
tistical package (SPSS version 13.0, Chicago, IL). Contin-
uous values were presented as mean ± SD and all tests
were two-tailed. P < 0.05 was considered statistically
significant.
Results
Table 1 showed the comparison of characteristics and
COH parameters between pregnant and non-pregnant
(excluded patients who did not have embryo transferred)
women in Group 1 and 2. In Group 1, basal T levels
were significantly higher in the pregnant women than
that in non-pregnant ones (p < 0.05), while as not in
Group 2. When adjusting for age yielded similar results.
It seemed that pregnant women in Group 1 had more
good quality embryos, embryos cryopreservered and
more gonadotropins used than non-pregnant patients.
In Group 1, pearson rank correlation analysis showed
positive associations between basal T levels with the
number of follicles >14 mm on HCG day, but negative
associations with age, days of stimulation and total dose
of gonadotropins used. When adjusting for age yielded
similar results (Table 2). In the pearson rank correlation
analysis, the characteristics associated with number of
follicles >14 mm on HCG day were age, BMI, AFC, basal
T levels, basal FSH levels, basal LH levels and starting
dose of gonadotropins, respectively (data not shown). For
total dose of gonadotropins, the associated characteristics
were age, BMI, AFC, basal T levels, basal FSH levels and
starting dose of gonadotropins, respectively (data not
shown). And the characteristics correlated with days of
stimulation were basal T levels and AFC (data not
shown). Accordingly, multiple linear regression analysis
were performed to study the major independent factors
for number of follicles >14 mm on HCG day, total dose
of gonadotropins and days of stimulation which were
used as the dependent variable, whereas independent
variables included the characteristics showing significant
correlations mentioned above respectively (Table 3, 4, 5).
Basal T level was an independent factor for number of
follicles >14 mm on HCG day, total dose of gonadotro-
pins and days of stimulation. For number of follicles >14
mm on HCG day, the influencing independent factor
with decreasing importance were basal FSH levels, AFC,
basal LH levels, basal T levels and age. For total dose of
gonadotropins, the largest influencing independent factor
Table 1 The comparison of characteristics and COH parameters between pregnant and non-pregnant women
Group 1 Group 2
Variables Non-pregnant cycles
n = 89)
Pregnant cycles
(n = 72)
P value Non-pregnant cycles
(n = 403)
Pregnant cycles
(n = 518)
P value
Age (years) 32.2 ± 4.0 32.7 ± 3.8 0.352 31.9 ± 4.0 31.1 ± 4.1 0.003
BMI (kg/m
2) 22.4 ± 2.9 2.2 ± 2.6 0.696 9.4 ± 1.5 9.4 ± 1.4 0.312
Pregnancy history 0.6 ± 0.5 0.6 ± 0.5 0.628 9.0 ± 3.9 9.0 ± 3.8 0.930
Basal FSH levels (IU/L) 11.8 ± 1.9 11.6 ± 1.7 0.424 7.5 ± 1.4 7.5 ± 1.4 0.947
Basal LH levels (IU/L) 5.4 ± 1.9 5.0 ± 2.1 0.260 4.3 ± 2.2 4.3 ± 2.2 0.974
Basal E2 levels (pg/ml) 43.3 ± 20.8 41.6 ± 18.3 0.581 43.3 ± 30.5 41.2 ± 31.4 0.300
Basal T levels (ng/dl) 48.3 ± 17.3 40.8 ± 18.1 0.008 47.8 ± 18.9 47.7 ± 19.9 0.907
Antral follicle count 9.8 ± 4.3 8.6 ± 4.6 0.099 11.6 ± 5.5 11.2 ± 5.7 0.217
Starting dose of gonadotropins (IU) 223.3 ± 54.6 228.1 ± 67.3 0.617 203.6 ± 36.7 198.6 ± 40.7 0.053
Number of oocytes retrieved 10.0 ± 4.4 9.0 ± 4.7 0.171 12.4 ± 5.4 12.4 ± 5.3 0.999
Number of follicles >14 mm 7.8 ± 3.5 7.1 ± 3.5 0.176 9.0 ± 3.9 9.0 ± 3.8 0.761
Days of stimulation 9.7 ± 1.6 10.5 ± 1.9 0.002 9.4 ± 1.5 9.4 ± 1.4 0.744
Total dose of gonadotropins (IU) 2477.8 ± 873.9 2936.1 ± 1249.9 0.010 2174.2 ± 826.8 2042.3 ± 728.7 0.012
Endometrial thickness on HCG day (cm) 1.1 ± 0.2 1.1 ± 0.2 0.521 1.0 ± 0.2 1.1 ± 0.2 0.001
Fertilization rate 0.8 ± 0.2 0.7 ± 0.2 0.202 0.7 ± 0.2 0.7 ± 0.2 0.615
Number of embryos cryopreserved 3.3 ± 2.9 2.4 ± 2.4 0.034 3.9 ± 3.4 4.1 ± 3.2 0.256
Number of good quality embryos 5.6 ± 2.9 4.5 ± 2.5 0.015 6.0 ± 3.4 6.3 ± 3.2 0.219
Note: Data other than P values are mean ± SD.
Dichotomy variable pregnancy history was represented by secondary infertility = 1 and primary infertility = 0.
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importance, basal FSH levels and basal T levels in order.
For days of stimulation, the only influencing independent
factor was basal T levels.
Table 6 shows the ROC curve analysis of the diagnos-
tic accuracy of discriminination between pregnancy per
transfer versus non-pregnancy per transfer, spontaneous
miscarriage and non-spontaneous miscarriage. In the
ROC model, basal T levels are predictive of pregnancy
outcome in Group 1. A basal T level of 47.85 ng/dl was
shown to predict pregnancy outcome with a sensitivity
of 52.8% and specificity of 65.3%.
Discussion
Androgen actions via the AR play an important role in
female fertility [17,18]. It is believed that AR signaling in
granulosa cells (GCs) is necessary for normal follicular
growth and progression beyond preantral stage [19].
Inhibition of ARs slows mouse follicle growth [20],
decreases the diameter of mouse follicles [21,22] and
induces GC degeneration and follicular apoptosis. Low
numbers of antral follicles, ovulated oocytes, and a high
rate of follicular atresia were found in the global and
GC-specific ARKO mice [23,24]. In this study, basal
T level in women with diminished ovarian reserve
Table 2 Spearman correlation analysis of associations between basal T levels and the characteristics and COH
parameters
Group 1 Group 2
Variables r value P value r value
a P value
a r value P value r value
b P value
b
Age (years) -0.163 0.026 - - -0.151 <0.001 - -
BMI (kg/m
2) -0.054 0.308 -0.009 0.907 -0.063 0.038 - -
Pregnancy history -0.031 0.669 0.013 0.859 -0.033 0.276 0.011 0.714
Basal FSH level (IU/L) -0.051 0.068 -0.032 0.664 0.028 0.361 0.033 0.281
Basal LH level (IU/L) 0.026 0.722 0.007 0.927 0.080 0.009 - -
Basal E2 level (pg/ml) 0.141 0.054 0.134 0.069 -0.044 0.150 -0.036 0.239
Antral follicle count 0.026 0.724 0.002 0.979 0.044 0.151 0.015 0.631
Starting dose of gonadotropins (IU) -0.088 0.434 -0.009 0.902 -0.124 <0.001 - -
Basal FSH/LH ratio -0.014 0.849 0.013 0.856 -0.056 0.065 0.006 0.839
Numbers of oocytes retrieved 0.115 0.117 0.063 0.394 0.064 0.037 0.009 0.766
Number of follicles >14 mm 0.191 0.009 0.147 0.047 0.013 0.679 -0.036 0.246
Days of stimulation -0.174 0.017 -0.177 0.016 -0.076 0.013 -0.066 0.031
Total dose of gonadotropins (IU) -0.203 0.005 -0.155 0.035 -0.139 <0.001 -0.081 0.008
Endometrial thickness on HCG day (cm) 0.120 0.102 0.093 0.211 -0.027 0.380 -0.041 0.177
Fertilization rate -0.010 0.893 -0.007 0.930 -0.007 0.828 0.003 0.922
Number of embryos cryopreserved 0.069 0.347 0.020 0.791 0.058 0.058 0.009 0.766
Number of good quality embryos 0.060 0.412 0.022 0.771 0.040 0.190 0.002 0.956
Live births -0.009 0.906 -0.022 0.765 -0.024 0.427 -0.023 0.452
Note:
a represent the r value and P value after adjusting for age that associated with basal testosterone levels.
b represent the r value and P value after adjusting for age, basal LH level, BMI and starting dose of gonadotropins that associated with basal testosterone levels.
Dichotomy variable pregnancy history was represented by secondary infertility = 1 and primary infertility = 0.
Table 3 Multiple linear regression analysis of possible determinants for number of follicles >14 mm in Group 1
Coefficients
Unstandardized coefficients Standardized coefficients
Independent variables b Std. Error b t P value
(constant) 15.654 3.387 4.622 <0.001
Age (years) -0.151 0.074 -0.157 -2.027 0.044
BMI (kg/m
2) -0.092 0.100 -0.066 -0.915 0.361
Basal T levels (ng/dl) 0.028 0.014 0.136 2.032 0.044
Basal FSH level (IU/L) -0.414 0.126 -0.227 -3.288 0.001
Basal LH level (IU/L) 0.330 0.134 0.175 2.459 0.015
Antral follicle count 0.150 0.054 0.186 2.777 0.006
Starting dose of gonadotropins (IU) -0.003 0.005 -0.047 -0.624 0.534
Note: The dependent variable is number of follicles >14 mm. The model (r = 0.475, r
2 = 0.225, adjusted r
2 = 0.195, P < 0.001).
The values of the standardized coefficients reflect the independent contributions of each predictor to dependent variables.
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(>14 mm) significantly. This is in agreement with pre-
vious studies mentioned above.
With IVF being an invasive, stressful, time-consuming
and expensive treatment, it is important to help couples
select the best individualized strategy for COH. Predict-
ing the ovarian response is useful in ameliorating subse-
quent disappointment and distress of potential poor
responders as well as in optimizing the gonadotropins
stimulation protocol to obtain a good response.
Although no significant association between basal T
levels and oocytes retrieved was found, basal T level is
an independent factor for both days of stimulation and
total dose of gonadotropins in both groups. In other
words, in order to reach similar ovarian response,
patients with lower basal T levels needed more days and
more doses of gonadotropins otherwise they might show
poor ovarian response.
Basal FSH/LH ratio is suggested to predict ovarian
response and IVF outcome, although the definite thresh-
old value is still controversial [25,26]. We assessed the
correlation of basal FSH/LH ratio and basal T level for
the first time in the present study and found no signifi-
cant association in the two groups. Further prospective
studies are needed to elucidate the subject.
The application of basal serum T levels for predicting
pregnancy outcome is debated. John L et al. suggested
basal testosterone levels ≤ 20 ng/dL was associated with
poor IVF success rates [27]. But later, the same group
and Barbieri RL denied the predictive value in other stu-
dies [15,28]. In this study, we showed for the first time
that basal T level could predict pregnancy outcome in
women with diminished ovarian reserve. We compared
the relative performance of basal T level with basal FSH,
basal E2 and AFC using ROC curve further as a predic-
tor of pregnancy outcome in Group 1. Only basal T
levels was a significant indicator for pregnancy outcome.
There is no report focusing on the relationship between
basal T level and spontaneous miscarriage outcome at
present. Our results showed that, on pregnancy out-
come, basal T levels had minimal effects, and for the
first time, no association with spontaneous miscarriage.
As is known to all, a successful IVF treatment is depen-
dent on ovarian response, as well as oocyte quality, male
factors and endometrial factors. Although basal T level
is associated with potential ovarian response in women
with normal ovarian reserve according to the present
study, it could not predict the pregnancy outcome as
expected.
A weakness of this study is only basal serum testoster-
one level, which is ovarian androgen, was evaluated.
DHEA and other adrenal androgens are also very impor-
t a n ta ss h o w ni np r e v i o u ss t u dies [6,29]. Further pro-
spective investigations on adrenal androgens are
warranted in prospective studies.
O n es t r e n g t ho fo u rs t u d yi st h el a r g e s ts a m p l es i z e
(total 1260 patients) so far. Secondly, different from pre-
vious studies [15,27,28], the population we investigated
Table 4 Multiple linear regression analysis of possible determinants for total dose of gonadotropins in Group 1
Coefficients
Unstandardized coefficients Standardized coefficients
Independent variables b Std. Error b t P value
(constant) -464.984 819.634 -0.567 0.571
Age (years) -8.988 18.659 -0.032 -0.482 0.631
BMI (kg/m
2) 40.781 25.082 0.098 1.626 0.106
Basal T levels (ng/dl) -8.833 3.516 -0.145 2.512 0.013
Basal FSH level (IU/L) 89.904 31.525 0.166 2.852 0.005
Antral follicle count -26.244 13.797 -0.109 -1.902 0.059
Starting dose of gonadotropins (IU) 9.633 1.168 0.531 8.244 <0.001
Note: The dependent variable is total dose of gonadotropins. The model (r = 0.647, r
2 = 0.419, adjusted r
2 = 0.399, P < 0.001).
The values of the standardized coefficients reflect the independent contributions of each predictor to dependent variables.
Table 5 Multiple linear regression analysis of possible determinants for days of stimulation
Coefficients
Unstandardized coefficients Standardized coefficients
Independent variables b Std. Error b t P value
(constant) 11.388 0.427 26.661 <0.001
Basal T levels (ng/dl) -0.017 0.007 -0.170 -2.367 0.019
Antral follicle count -0.054 0.028 -0.141 -1.964 0.051
Note: The dependent variable is days of stimulation. The model (r = 0.224, r
2 = 0.050, adjusted r
2 = 0.040, P = 0.009).
The values of the standardized coefficients reflect the independent contributions of each predictor to dependent variables.
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of protocols used other than long protocol was ruled
out. And we adjusted for confounding variables includ-
ing age, BMI, treatment cycles, infertility history and
starting dose of gonadotropins given their possible asso-
ciations with basal serum T levels. It is reported that
age, BMI and causes of infertility may involve in ovarian
response and/or pregnancy outcome [30-32]. Therefore,
patients in our study were matched for these variables,
allowing the analysis of basal T levels as an independent
marker for test variables. Besides, although this is a ret-
rospective study, ascertainment and recall bias were
minimized as all the data were collected and recorded
in the computerized database.
Conclusions
Basal T level is a good predictor for pregnancy outcome
and number of large follicles on HCG day in women
with diminished ovarian reserve. Basal T level is equally
helpful in tailoring the dosage of gonadotropins to indi-
vidual and identifying potential poor ovarian responders,
subsequently, making individualized COH strategy
before entering IVF cycles. It also gives evidence to
androgen supplementation in infertile women. Those
patients with lower basal T levels would benefit from T
supplementation during COH, such as improving
response, decreasing the amount of gonadotropins used
and the cost accordingly.
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